149246-81-1 Usage
General Description
5-(3-Bromo-phenyl)-2H-pyrazol-3-ylamine is a chemical compound with the molecular formula C9H8BrN3. It is a pyrazole derivative that contains a bromine-substituted phenyl group and an aminopyrazole group. 5-(3-BROMO-PHENYL)-2H-PYRAZOL-3-YLAMINE has potential applications in pharmaceutical research and development, as it may have biological activity and therapeutic properties. It can be used as a building block or intermediate in the synthesis of various pharmaceutical compounds. The chemical properties and reactivity of 5-(3-Bromo-phenyl)-2H-pyrazol-3-ylamine make it a valuable component in the production of drug candidates and other biologically active molecules. Therefore, it is of interest to researchers in the pharmaceutical and chemical industries for its potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 149246-81-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,2,4 and 6 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 149246-81:
(8*1)+(7*4)+(6*9)+(5*2)+(4*4)+(3*6)+(2*8)+(1*1)=151
151 % 10 = 1
So 149246-81-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H8BrN3/c10-7-3-1-2-6(4-7)8-5-9(11)13-12-8/h1-5H,(H3,11,12,13)
149246-81-1Relevant articles and documents
PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
-
Page/Page column 19, (2015/09/22)
The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
-
Paragraph 21; 22, (2015/09/23)
The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INHIBITORS
-
Page/Page column 128, (2010/04/03)
The present invention provides compounds and compositions, methods of making them, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can a